يعرض 1 - 10 نتائج من 32 نتيجة بحث عن '"Hedghog"', وقت الاستعلام: 0.90s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
  3. 3

    المصدر: Acta Pharmaceutica Sinica B, Vol 11, Iss 2, Pp 309-321 (2021)
    Acta Pharmaceutica Sinica. B

    مصطلحات موضوعية: SRC-3, nuclear receptor coactivator 3, VHL, von Hippel-Lindau tumor suppressor, RRM2, ribonucleotide reductase regulatory subunit M2, KRAS, KRAS proto-oncogene, GTPase, SNAIL1, snail family transcriptional repressor 1, medicine.medical_treatment, CRL, cullin-RING ligase, ERK, mitogen-activated protein kinase 1, NEDD8, NEDD8 ubiquitin like modifier, Review, medicine.disease_cause, JAB1, c-Jun activation domain binding protein-1, p130Cas, BCAR1 scaffold protein, Cas family member, law.invention, Targeted therapy, Degradation, 0302 clinical medicine, Ubiquitin, law, RA, retinoic acid, FBXL3, F-box and leucine rich repeat protein, Ci, cubitus interruptus, Phosphorylation, General Pharmacology, Toxicology and Pharmaceutics, Crosstalk, FBXO3/31, F-box protein 3/31, 0303 health sciences, biology, KEAP1, kelch like ECH associated protein 1, Kinase, Chemistry, KBTBD8, kelch repeat and BTB domain containing 8, CSN, COP9 signalosome, DYRK1A/B, dual-specificity tyrosine-phosphorylation-regulated kinases 1A/B, FBW7, F-box and WD repeat domain containing 7, CDT2, denticleless E3 ubiquitin protein ligase homolog, NRF2, nuclear factor, erythroid 2 like 2, TCN, triciribine hydrate, Cell biology, USP37, ubiquitin specific peptidase 37, Crosstalk (biology), XBP1, X-box binding protein 1, 030220 oncology & carcinogenesis, HCC, hepatocellular carcinomas, Vps34, phosphatidylinositol 3-kinase catalytic subunit type 3, CK1/2, casein kinase I/II, COMMD1, copper metabolism domain containing 1, KLHL3, kelch like family member 3, EMT, epithelial–mesenchymal transition, Cullin, P-TEFb, positive transcription elongation factor b, CDK2/4, cyclin dependent kinase 2/4, SPOP, speckle-type POZ protein, AIRE, autoimmune regulator, PYGO2, pygopus 2, TCOF1, treacle ribosome biogenesis factor 1, ID2, inhibitor of DNA binding 2, CHK1, checkpoint kinase 1, Kinases, FZR1, fizzy and cell division cycle 20 related 1, HIF1α, NF-κB and hypoxia inducible factor 1 subunit alpha, EXO1, exonuclease 1, ZBTB16, zinc finger and BTB domain containing 16, NOLC1, nucleolar and coiled-body phosphoprotein 1, 03 medical and health sciences, PKM2, pyruvate kinase M2 isoform, KDM2B, lysine demethylase 2B, PKC, protein kinase C, Cullin-RING ligases, medicine, BMAL1, aryl hydrocarbon receptor nuclear translocator like, ATR, ataxia telangiectasia-mutated and Rad3-related, SOCS6, suppressor of cytokine signaling 6, 030304 developmental biology, PDL1, programmed death ligand 1, HIB, Hedghog-induced MATH and BTB domain-containing protein, AKT, AKT serine/threonine kinase, lcsh:RM1-950, Ubiquitination, TRF1, telomeric repeat binding factor 1, DDB1, damage specific DNA binding protein 1, BCL2, BCL2 apoptosis regulator, CLOCK, clock circadian regulator, MYC, MYC proto-oncogene, bHLH transcription factor, lcsh:Therapeutics. Pharmacology, c-Fos, Fos proto-oncogene, AP-1 transcription factor subunit, RARα, RA receptor α, Tumorigenesis, biology.protein, Suppressor, CRY1, cryptochrome circadian regulator 1, ERG, ETS transcription factor ERG, Carcinogenesis

  4. 4
  5. 5
  6. 6
  7. 7
    دورية أكاديمية

    لا يتم عرض هذه النتيجة على الضيوف.

  8. 8
    دورية أكاديمية

    لا يتم عرض هذه النتيجة على الضيوف.

  9. 9

    المساهمون: Institut Cochin (IC UM3 (UMR 8104 / U1016)), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Centre de Recherche en Cancérologie Nantes-Angers (CRCNA), Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM)-PRES Université Nantes Angers Le Mans (UNAM)-Hôtel-Dieu de Nantes-Institut National de la Santé et de la Recherche Médicale (INSERM)-Hôpital Laennec-Centre National de la Recherche Scientifique (CNRS)-Faculté de Médecine d'Angers-Centre hospitalier universitaire de Nantes (CHU Nantes), This research was funded by:Liguenationalecontrelecancer,InstitutNationalduCancer,RegionPays-de-la-Loire, andNantes Metropole. SA and LT are supported byfellowships fromFondation ARC Association pour la Recherche surle CancerandUniversite Paris Descartes, respectively., Bos, Mireille, Institut Cochin ( UM3 (UMR 8104 / U1016) ), Université Paris Descartes - Paris 5 ( UPD5 ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Centre National de la Recherche Scientifique ( CNRS ), Centre de Recherche en Cancérologie / Nantes - Angers ( CRCNA ), CHU Angers-Hôtel-Dieu de Nantes-Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Hôpital Laennec-Centre National de la Recherche Scientifique ( CNRS ) -Faculté de Médecine d'Angers-Centre hospitalier universitaire de Nantes ( CHU Nantes )

    المصدر: Frontiers in Pharmacology
    Frontiers in Pharmacology, 2015, ⟨10.3389/fphar.2015.00281⟩
    Frontiers in Pharmacology, Vol 6 (2015)
    Frontiers in Pharmacology, Frontiers, 2015, ⟨10.3389/fphar.2015.00281⟩
    Frontiers in Pharmacology, Frontiers, 2015, 〈10.3389/fphar.2015.00281〉

    وصف الملف: application/pdf

  10. 10

    المصدر: Biochemical Journal

    مصطلحات موضوعية: Lung Neoplasms, Oncogene Proteins, Fusion, Review Article, Biochemistry, midkine, Receptor tyrosine kinase, Cdc42, cell division cycle 42, inflammatory myofibroblastic tumour (IMT), TGFβ, transforming growth factor β, Anaplastic lymphoma kinase, Anaplastic Lymphoma Kinase, RPTP, receptor protein tyrosine phosphatase, Anaplastic large-cell lymphoma, Jeb, jelly belly, TPM, tropomyosin, SCD-2, suppressor of constitutive dauer 2, Kinase, STAT, signal transducer and activator of transcription, FRS2, fibroblast growth factor receptor substrate 2, IR, insulin receptor, RTK, receptor tyrosine kinase, JAK, Janus kinase, Nucleophosmin, MAM, meprin, A5 protein and receptor protein tyrosine phosphatase mu, mTOR, mammalian target of rapamycin, ERK, extracellular-signal-regulated kinase, HEK, human embryonic kidney, PLCγ, phospholipase Cγ, MSN, moesin, Humans, Dpp, decapentaplegic, Molecular Biology, CML, chronic myeloid leukaemia, LTK, leucocyte tyrosine kinase, NPM, nucleophosmin, ALK, anaplastic lymphoma kinase, UCN-01, unco-ordinated 1, Receptor Protein-Tyrosine Kinases, medicine.disease, anaplastic large cell lymphoma (ALCL), DRG, dorsal root ganglia, Insulin receptor, MYH9, non-muscle myosin heavy chain, MEK, MAPK/ERK kinase, MK, midkine, GIST, gastrointestinal stromal tumour, IMT, inflammatory myofibroblastic tumour, LDLa, low-density lipoprotein class A, PTN, pleiotrophin, MAPK, mitogen-activated protein kinase, SCC, squamous cell carcinoma, Shp1, SH2 domain-containing phosphatase 1, Neuroblastoma, FOXO3a, forkhead box O 3a, hemic and lymphatic diseases, Carcinoma, Non-Small-Cell Lung, ATIC, 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase, SHH, sonic hedghog, biology, extracellular-signal-regulated kinase (ERK), NIPA, nuclear interacting partner of ALK, Nuclear Proteins, C/EBPβ, CCAAT/enhancer-binding protein β, Protein-Tyrosine Kinases, TFG, TRK-fused gene, Shc, Src homology and collagen homology, RANBP2, Ran-binding protein 2, JNK, c-Jun N-terminal kinase, CARS, cysteinyl-tRNA synthetase, SEC31L1, SEC31 homologue A, Lymphoma, Large-Cell, Anaplastic, Hen-1, hesitation-1, Signal transduction, NF-κB, nuclear factor κB, DLBCL, diffuse large B-cell lymphoma, PI3K, phosphoinositide 3-kinase, SH2, Src homology 2, Signal Transduction, PKB, protein kinase B, CNS, central nervous system, Models, Biological, CLTC, clathrin heavy chain, NSCLC, non-small cell lung cancer, medicine, ALCL, anaplastic large cell lymphoma, IRS-1, IR substrate-1, BCR-Abl, breakpoint cluster region-Abl, EML4, echinoderm microtubule-associated protein like 4, Grb2, growthfactor-receptor-bound protein 2, IL-3, interleukin-3, Cancer, Cell Biology, EGFR, epidermal growth factor receptor, non-small cell lung cancer (NSLCL), anaplastic lymphoma kinase (ALK), dALK, Drosophila ALK, ALO17, ALK lymphoma oligomerization partner on chromosome 17, biology.protein, Cancer research, pleiotrophin, MUC-1, mucin-1